Allegaert, K., M. Rayyan, V. Cossey, and C. Van Geet. “Subcutaneous Palivizumab (Synagis®) Administration in an Infant With Congenital Type 2B Von Willebrand Disease”. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM), vol. 4, no. 1, Jan. 2015, p. e040104, doi:10.7363/040104.